首页> 外文期刊>Current medical research and opinion >Predicting risk for radiographic damage in rheumatoid arthritis: comparative analysis of the multi-biomarker disease activity score and conventional measures of disease activity in multiple studies
【24h】

Predicting risk for radiographic damage in rheumatoid arthritis: comparative analysis of the multi-biomarker disease activity score and conventional measures of disease activity in multiple studies

机译:类风湿性关节炎中辐射学损伤的风险:多生物标志物疾病活动评分的比较分析及多种研究中疾病活动的常规措施

获取原文
获取原文并翻译 | 示例
           

摘要

Objective: To compare the multi-biomarker disease activity (MBDA) score with the DAS28-CRP and CRP for predicting risk of radiographic progression in patients with rheumatoid arthritis. Methods: Published studies of the MBDA score and radiographic progression with >= 100 patients per cohort were evaluated. Rates of radiographic progression over 1 year were determined across the low/moderate/high categories for MBDA score (low/moderate/high: 44), DAS28-CRP (low/moderate/high: 2.67-4.09, >4.09) and CRP (low/moderate/high: 10-30, >30 mg/L), with positive and negative predictive value (PPV, NPV) and relative risk (RR) determined for high vs. not-high (i.e. low and moderate combined) categories. Patient-level data from studies having all three measures was pooled to: (1) determine a combined RR for radiographic progression in the high vs. not-high categories for each measure; and (2) compare the predictive ability of MBDA score vs. DAS28-CRP by comparing the rates of radiographic progression observed in subgroups created by cross-classifying the high and not-high categories of each measure. Results: Five cohorts were identified for inclusion (total N=929). In each, radiographic progression was more frequent with increasing MBDA scores. Among the three cohorts with requisite data, PPVs were generally similar using categories of MBDA score, DAS28-CRP or CRP but NPVs were greater for MBDA score (93-97%) than DAS28-CRP or CRP (77-87%). RRs for radiographic progression were greater when based on categories of MBDA score than DAS28-CRP or CRP and the combined RR was greater for MBDA score (4.6, p < .0001) than DAS28-CRP (1.7, p = .02) or CRP (1.7, p = .002). For patients cross-classified by MBDA score and DAS28-CRP, high vs. not-high MBDA score significantly predicted radiographic progression independently of DAS28-CRP. Conclusions: High and not-high MBDA scores were associated with increased and low risk, respectively, for radiographic progression over one year. MBDA score was a better predictor of radiographic progression than DAS28-CRP or CRP.
机译:目的:比较与DAS28-CRP和CRP的多生物标志物疾病活动(MBDA)得分,用于预测类风湿性关节炎患者的放射线进展风险。方法:评价对MBDA评分和射线照相进展的研究评价> = 100名患者。在低/中等/高级的MBDA得分(低/中等/高:44),DAS28-CRP(低/中等/高:2.67-4.09,> 4.09)和CRP(低/中度/高:10-30,> 30 mg / L),具有阳性和负预测值(PPV,NPV)和相对风险(RR),用于高与高(即低和中等组合)类别。汇集了来自所有三项措施的研究的患者水平数据:(1)确定每种措施的高与高类别的放射线进展的组合RR; (2)通过比较通过交叉分类每种措施的高度和高类别创建的亚组中观察到的亚群中观察到的射线照相进展的速率来比较MBDA得分与DAS28-CRP的预测能力。结果:鉴定了五个群组夹杂物(总N = 929)。在每种情况下,随着MBDA分数的增加,放射线进展更频繁。在具有必要数据的三个群组中,PPV通常使用MBDA得分类别,DAS28-CRP或CRP,但NPVS比DAS28-CRP或CRP(77-87%)更大。基于MBDA分数的基于DAS28-CRP或CRP的类别,MBDA评分(4.6,P <701)的CBDA评分(1.7,P = .02)或CRP,RRS的RRS更大(1.7,p = .002)。对于MBDA得分和DAS28-CRP交叉分类的患者,高与高MBDA评分的显着预测射线照相进展,独立于DAS28-CRP。结论:高且不高的MBDA分别与一年内的放射学进展分别有关的增加和低风险。 MBDA评分比DAS28-CRP或CRP更好地预测射线照相进展。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号